FLUTE Cross-border Prostate Cancer Data Standard Guide
0.1.0 - ci-build
FLUTE Cross-border Prostate Cancer Data Standard Guide
0.1.0 - ci-build
FLUTE Cross-border Prostate Cancer Data Standard Guide, published by Flute Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/flute/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7.eu/fhir/ig/flute/StructureDefinition/InclusionCriterias | Version: 0.1.0 | |||
| Draft as of 2025-11-05 | Computable Name: InclusionCriterias | |||
Criteria for including men in cohorts based on clinical suspicion of prostate cancer.
Usages:
You can also check for usages in the FHIR IG Statistics
Description of Profiles, Differentials, Snapshots and how the different presentations work.
| Name | Flags | Card. | Type | Description & Constraints Filter:   |
|---|---|---|---|---|
  InclusionCriterias |
0..* | Base | Inclusion Criteria for Prostate Cancer Cohorts | |
  psa |
0..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
  dre |
0..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
| Documentation for this format | ||||
This structure is derived from Base
| Name | Flags | Card. | Type | Description & Constraints Filter: |
|---|---|---|---|---|
| InclusionCriterias |
0..* | Base | Inclusion Criteria for Prostate Cancer Cohorts | |
| psa |
0..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
| dre |
0..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
| Documentation for this format | ||||
| Name | Flags | Card. | Type | Description & Constraints Filter: |
|---|---|---|---|---|
| InclusionCriterias |
0..* | Base | Inclusion Criteria for Prostate Cancer Cohorts | |
| psa |
0..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
| dre |
0..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
| Documentation for this format | ||||
This structure is derived from Base
Key Elements View
| Name | Flags | Card. | Type | Description & Constraints Filter: |
|---|---|---|---|---|
| InclusionCriterias |
0..* | Base | Inclusion Criteria for Prostate Cancer Cohorts | |
| psa |
0..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
| dre |
0..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
| Documentation for this format | ||||
Differential View
This structure is derived from Base
| Name | Flags | Card. | Type | Description & Constraints Filter: |
|---|---|---|---|---|
| InclusionCriterias |
0..* | Base | Inclusion Criteria for Prostate Cancer Cohorts | |
| psa |
0..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
| dre |
0..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
| Documentation for this format | ||||
Snapshot View
| Name | Flags | Card. | Type | Description & Constraints Filter: |
|---|---|---|---|---|
| InclusionCriterias |
0..* | Base | Inclusion Criteria for Prostate Cancer Cohorts | |
| psa |
0..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
| dre |
0..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
| Documentation for this format | ||||
This structure is derived from Base